@xiliotx [Video description: On-screen text reads, "Oncology News."]

@US_FDA [Video description: On-screen text reads, "Specialty News."]

@RicanMashaM Hello @ricanMashaM, we saw your tweet. So we can better help, please follow us so we can DM you to get more information.

[Image description: A series of infographics outlining how antibody-drug conjugates (ADCs) work.]

[“Biomarker testing can help physicians evaluate targeted treatment options and tailor care to each individual's needs. Everyone’s cancer journey is deeply personal, and that’s what makes us #UnitedByUnique.”]

[Image description: On-screen text reads, "Every person’s cancer is different. Biomarker testing can help doctors diagnose and understand each person’s unique cancer. Biomarkers can also be used to monitor cancer’s progression and help guide decisions around targeted treatment."]

#ICYMI: This morning we released our full-year and Q4 2024 #FinancialResults. Learn more and see some of our milestones from the previous year: $ABBV #earnings

Join us live: Our full-year and Q4 2024 #earnings call is starting: $ABBV

["Our growth platform delivered outstanding results, we advanced our pipeline with key regulatory approvals and promising data, and we strengthened our business through strategic transactions. We are entering 2025 with significant momentum."]

Reminder: Join us tomorrow at 8am CT as we share our full-year and Q4 2024 #FinancialResults. #earnings $ABBV

Join our #investor call this Friday, January 31, at 8am CT, where we’ll share our full-year and Q4 2024 #FinancialResults. #earnings $ABBV

We've entered a partnership with @neomorphinc to develop novel molecular glue degraders for multiple targets across #oncology and #immunology. Read more: